Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 58,119,888
- Share change
- +2,119,709
- Total reported value
- $194,118,470
- Put/Call ratio
- 4%
- Price per share
- $3.34
- Number of holders
- 92
- Value change
- +$7,244,002
- Number of buys
- 46
- Number of sells
- 21
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
8.9%
|
11,370,376
|
$33,883,720 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
5.8%
|
7,381,090
|
$21,995,648 | — | 30 Jun 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
3.9%
|
5,026,931
|
$14,980,254 | — | 30 Jun 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
3.4%
|
4,400,000
|
$13,112,000 | — | 30 Jun 2024 | |
| VR Adviser, LLC |
13F
|
Company |
2.7%
|
3,422,637
|
$10,199,458 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.4%
|
3,135,115
|
$9,342,643 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
2.2%
|
2,800,000
|
$8,344,000 | — | 30 Jun 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
2.1%
|
2,645,000
|
$7,882,100 | — | 30 Jun 2024 | |
| TPG GP A, LLC |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
3,824,883
|
$7,726,264 | — | 01 Jul 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
2,437,451
|
$7,263,603 | — | 30 Jun 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
1.2%
|
1,510,174
|
$4,500,319 | — | 30 Jun 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
1.2%
|
1,474,926
|
$4,395,279 | — | 30 Jun 2024 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
1.1%
|
1,391,577
|
$4,146,899 | — | 30 Jun 2024 | |
| MAI Capital Management |
13F
|
Company |
1%
|
1,318,496
|
$3,929,118 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
1,146,748
|
$3,417,619 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.7%
|
899,861
|
$2,681,586 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
844,235
|
$2,515,820 | — | 30 Jun 2024 | |
| Peter W. Sonsini |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
3,948,948
mixed-class rows
|
$1,916,875 | — | 11 Apr 2022 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.47%
|
605,442
|
$1,804,217 | — | 30 Jun 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.39%
|
500,089
|
$1,490,265 | — | 30 Jun 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
0.32%
|
405,988
|
$1,209,844 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.25%
|
321,102
|
$956,884 | — | 30 Jun 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.2%
|
260,000
|
$774,800 | — | 30 Jun 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.2%
|
260,000
|
$774,800 | — | 30 Jun 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.16%
|
200,000
|
$596,000 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
185,481
|
$552,733 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
178,511
|
$531,962 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
150,918
|
$449,736 | — | 30 Jun 2024 | |
| J. Goldman & Co LP |
13F
|
Company |
0.12%
|
148,917
|
$443,773 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
96,350
|
$287,123 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
88,981
|
$265,163 | — | 30 Jun 2024 | |
| Shay Capital LLC |
13F
|
Company |
0.07%
|
88,462
|
$263,617 | — | 30 Jun 2024 | |
| PFS Partners, LLC |
13F
|
Company |
0.06%
|
79,000
|
$235,420 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
75,218
|
$224,139 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
73,193
|
$218,115 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.06%
|
72,210
|
$214,990 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
66,368
|
$197,777 | — | 30 Jun 2024 | |
| WealthTrust Axiom LLC |
13F
|
Company |
0.05%
|
63,500
|
$189,230 | — | 30 Jun 2024 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.05%
|
60,819
|
$181,241 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.04%
|
54,108
|
$161,242 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
51,900
|
$154,662 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
44,284
|
$131,966 | — | 30 Jun 2024 | |
| BAILARD, INC. |
13F
|
Company |
0.03%
|
40,900
|
$121,882 | — | 30 Jun 2024 | |
| TRUST CO OF TOLEDO NA /OH/ |
13F
|
Company |
0.03%
|
36,502
|
$108,776 | — | 30 Jun 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
36,000
|
$107,280 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
33,915
|
$101,067 | — | 30 Jun 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.02%
|
31,595
|
$94,153 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
31,350
|
$93,422 | — | 30 Jun 2024 | |
| UNITED BANK |
13F
|
Company |
0.02%
|
31,200
|
$92,976 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
24,524
|
$73,082 | — | 30 Jun 2024 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q3 2024
As of 30 Sep 2024,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,119,888 shares.
The largest 10 holders included
NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, VANGUARD GROUP INC, BlackRock, Inc., Logos Global Management LP, Opaleye Management Inc., and Vivo Capital, LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
76
Q3 2024 holders
92
Holder diff
16
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.